Every day we seek to use the best technology to understand biomedical science and thus, solve the greatest unmet healthcare needs of our time. Through our Biotechnological Innovation department, located at the EuroEspes International Centre for Neuroscience and Genomic Medicine, and made up of a multidisciplinary team of experts in the fields of Biotechnology, Neuroscience, Epigenetics, and Biochemistry, we work, research, and invest in innovative and highly differentiated bioproducts that help to improve people's quality of life.


The Health Biotechnology department seeks to positively impact health through innovation and the development of healthy and revolutionary bioproducts in terms of efficacy, prevention, and epigenetic modulation.

Innovative research

The ideas that nourish our bioproducts’ innovation arise from the constant research of new bio-functional routes in natural extracts, obtained by exclusive patented biotechnological processes, which are constantly filtered with new concepts to improve health.        

Health Biotechnology
Health Biotechnology

Biotechnological development

Each area of innovation is designed to identify the latest scientific advances and best available technology to create successful collaborations with both private companies and public scientific bodies to develop new bioproducts, nutraceuticals, pharmaceuticals, and bio-functional consumer products.

R&D collaborations

We offer R&D solutions to companies with needs when planning, guiding, and executing R&D projects. We work closely with innovative companies throughout their journey, providing a strong exchange of ideas and resources to scientifically support their product and ensure its success.


Our R&D team has brought numerous successes in innovation and product development over the last decade.

State-of-the-art technology available to our R&D department

Our scientific results have international impact and are supported by cutting-edge methodologies and state-of-the-art biotechnological equipment.

Health Biotechnology

Industrial Scale-up R&D

The final formulation of the bioproducts developed, backed by scientific studies published in scientific journals of international impact, are converted into prototypes through industrial scale-up in our EBIOTEC industrial freeze-drying plant. The collaboration between R&D and industrialisation of the bioproduct is is done in a close and direct manner.

More information about our Neutraceuticals here.

Scientific production

1: Carrera I, Cacabelos R. Current Drugs and Potential Future Neuroprotective Compounds for Parkinson's Disease. Curr Neuropharmacol. 2019;17(3):295-306.


2: Carrera I, Fernandez-Novoa L, Sampedro C, Tarasov VV, Aliev G, Cacabelos R. Dopaminergic Neuroprotection with Atremorine in Parkinson's Disease. Curr Med Chem. 2018;25(39):5372-5388.


3: Cacabelos R, Carrera I, Alejo R, Fernández-Novoa L, Cacabelos P, Corzo L, Rodríguez S, Alcaraz M, Tellado I, Cacabelos N, Pego R, Carril JC. Pharmacogenetics of Atremorine-Induced Neuroprotection and Dopamine Response in Parkinson's Disease. Planta Med. 2019 Nov;85(17):1351-1362.


4: Carrera I, Martínez O, Cacabelos R. Neuroprotection with Natural Antioxidants and Nutraceuticals in the Context of Brain Cell Degeneration: The Epigenetic Connection. Curr Top Med Chem. 2019;19(32):2999 3011.


5: Cacabelos R, Torrellas C, Carrera I, Cacabelos P, Corzo L, Fernández-Novoa L, Tellado I, Carril JC, Aliev G. Novel Therapeutic Strategies for Dementia. CNS Neurol Disord Drug Targets. 2016;15(2):141-241.


6: Carrera I, Fernandez-Novoa L, Aliev G, Vigo C, Cacabelos R. Validating Immunotherapy in Alzheimer's Disease: The EB101 Vaccine. Curr Pharm Des. 2016;22(7):849-58.


7: Corzo L, Fernández-Novoa L, Carrera I, Martínez O, Rodríguez S, Alejo R, Cacabelos R. Nutrition, Health, and Disease: Role of Selected Marine and Vegetal Nutraceuticals. Nutrients. 2020 Mar 11;12(3):747.


8: Lombardi VRM, Carrera I, Corzo L, Cacabelos R. Role of bioactive lipofishins in prevention of inflammation and colon cancer. Semin Cancer Biol. 2019 Jun;56:175-184.


9: Perianes-Cachero A, Canelles S, Aguado-Llera D, Frago LM, Toledo-Lobo MV, Carrera I, Cacabelos R, Chowen JA, Argente J, Arilla-Ferreiro E, Barrios V. Reduction in Aβ-induced cell death in the hippocampus of 17β-estradiol-treated female rats is associated with an increase in IGF-I signaling and somatostatinergic tone. J Neurochem. 2015 Dec;135(6):1257-71.


Leave us your contact information and we will contact you.

Leave us your contact information and we will contact you.